Lsl Pharma Group Inc (LSL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 01-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,024 | 0 | 2,290 | 2,642 | 1,418 |
| Cost of Goods | 1,637 | N/A | 3,527 | 2,655 | 1,749 |
| Gross Profit | 387 | N/A | -1,237 | -13 | -332 |
| Operating Expenses | 1,578 | 3 | 882 | 1,113 | 1,316 |
| Operating Income | -1,191 | -3 | -2,119 | -1,126 | -1,648 |
| Interest Expense | 399 | 1 | 555 | 185 | 297 |
| Other Income | -2,543 | 0 | -342 | -156 | 607 |
| Pre-tax Income | -4,132 | -4 | -3,016 | -1,467 | -1,339 |
| Net Income Continuous | -4,132 | -4 | -3,016 | -1,467 | -1,339 |
| Net Income | $-4,132 | $-4 | $-3,016 | $-1,467 | $-1,339 |
| EPS Basic Total Ops | -0.06 | 0.00 | -0.04 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.06 | N/A | N/A | -0.01 | N/A |
| EPS Diluted Total Ops | -0.06 | 0.00 | -0.04 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.06 | N/A | N/A | -0.01 | N/A |
| EBITDA(a) | $-3,485 | $-3 | $-2,164 | $-1,033 | $-789 |